Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.021 AUD | -4.55% | -22.22% | -40.00% |
May. 16 | Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study | MT |
May. 02 | Chimeric Therapeutics Appoints COO; Shares Rise 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.00% | 12.02M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Appoints COO; Shares Rise 4%